Fingerprint
Dive into the research topics of 'A multi-institution phase i trial of ruxolitinib in patients with chronic myelomonocytic leukemia (CMML)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A multi-institution phase i trial of ruxolitinib in patients with chronic myelomonocytic leukemia (CMML)
Eric Padron, Amy Dezern, Marcio Andrade-Campos, Kris Vaddi, Peggy Scherle, Qing Zhang, Yan Ma, Maria E. Balasis, Sara Tinsley, Hanadi Ramadan, Cassandra Zimmerman, David P. Steensma, Gail J. Roboz, Jeffrey E. Lancet, Alan F. List, Mikkael A. Sekeres, Rami S. Komrokji
Research output: Contribution to journal › Article › peer-review
56
Scopus
citations